HIF1A and head and neck carcinoma: Chen et al. revealed that nanoparticulate delivery of HIF-1 siRNAs to head-and-neck carcinoma (SSC4) xenografts significantly enhanced photosan-PDT efficacy in mice [37], leading to 40 % tumor regression within 10 days post-PDT.